|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61K 31/506 | |||
| A61P 35/00 |
| (11) | Number of the document | 3110444 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15708638.0 |
| Date of filing the European patent application | 2015-02-19 | |
| (97) | Date of publication of the European application | 2017-01-04 |
| (45) | Date of publication and mention of the grant of the patent | 2018-01-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/016529 |
| Date | 2015-02-19 |
| (87) | Number | WO 2015/130540 |
| Date | 2015-09-03 |
| (30) | Number | Date | Country code |
| 201461944811 P | 2014-02-26 | US |
| (72) |
CHAN, Edward Michael, US
|
| (73) |
Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (54) | COMBINATION THERAPY FOR CANCER |
| COMBINATION THERAPY FOR CANCER |